
GenusPlus Group Ltd
ASX:GNP

GenusPlus Group Ltd?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.16
4.94
|
Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does GenusPlus Group Ltd hold over its rivals?
What risks and challenges
does GenusPlus Group Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of GenusPlus Group Ltd.
Provide an overview of the primary business activities
of GenusPlus Group Ltd.
What unique competitive advantages
does GenusPlus Group Ltd hold over its rivals?
What risks and challenges
does GenusPlus Group Ltd face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for GenusPlus Group Ltd.
Provide P/S
for GenusPlus Group Ltd.
Provide P/E
for GenusPlus Group Ltd.
Provide P/OCF
for GenusPlus Group Ltd.
Provide P/FCFE
for GenusPlus Group Ltd.
Provide P/B
for GenusPlus Group Ltd.
Provide EV/S
for GenusPlus Group Ltd.
Provide EV/GP
for GenusPlus Group Ltd.
Provide EV/EBITDA
for GenusPlus Group Ltd.
Provide EV/EBIT
for GenusPlus Group Ltd.
Provide EV/OCF
for GenusPlus Group Ltd.
Provide EV/FCFF
for GenusPlus Group Ltd.
Provide EV/IC
for GenusPlus Group Ltd.
Show me price targets
for GenusPlus Group Ltd made by professional analysts.
What are the Revenue projections
for GenusPlus Group Ltd?
How accurate were the past Revenue estimates
for GenusPlus Group Ltd?
What are the Net Income projections
for GenusPlus Group Ltd?
How accurate were the past Net Income estimates
for GenusPlus Group Ltd?
What are the EPS projections
for GenusPlus Group Ltd?
How accurate were the past EPS estimates
for GenusPlus Group Ltd?
What are the EBIT projections
for GenusPlus Group Ltd?
How accurate were the past EBIT estimates
for GenusPlus Group Ltd?
Compare the revenue forecasts
for GenusPlus Group Ltd with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of GenusPlus Group Ltd and its key competitors using the latest financial data.
Compare historical revenue growth rates
of GenusPlus Group Ltd against its competitors.
Analyze the profit margins
(gross, operating, and net) of GenusPlus Group Ltd compared to its peers.
Compare the P/E ratios
of GenusPlus Group Ltd against its peers.
Discuss the investment returns and shareholder value creation
comparing GenusPlus Group Ltd with its peers.
Analyze the financial leverage
of GenusPlus Group Ltd compared to its main competitors.
Show all profitability ratios
for GenusPlus Group Ltd.
Provide ROE
for GenusPlus Group Ltd.
Provide ROA
for GenusPlus Group Ltd.
Provide ROIC
for GenusPlus Group Ltd.
Provide ROCE
for GenusPlus Group Ltd.
Provide Gross Margin
for GenusPlus Group Ltd.
Provide Operating Margin
for GenusPlus Group Ltd.
Provide Net Margin
for GenusPlus Group Ltd.
Provide FCF Margin
for GenusPlus Group Ltd.
Show all solvency ratios
for GenusPlus Group Ltd.
Provide D/E Ratio
for GenusPlus Group Ltd.
Provide D/A Ratio
for GenusPlus Group Ltd.
Provide Interest Coverage Ratio
for GenusPlus Group Ltd.
Provide Altman Z-Score Ratio
for GenusPlus Group Ltd.
Provide Quick Ratio
for GenusPlus Group Ltd.
Provide Current Ratio
for GenusPlus Group Ltd.
Provide Cash Ratio
for GenusPlus Group Ltd.
What is the historical Revenue growth
over the last 5 years for GenusPlus Group Ltd?
What is the historical Net Income growth
over the last 5 years for GenusPlus Group Ltd?
What is the current Free Cash Flow
of GenusPlus Group Ltd?
Discuss the annual earnings per share (EPS)
trend over the past five years for GenusPlus Group Ltd.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
AU |
![]() |
GenusPlus Group Ltd
ASX:GNP
|
836.1m AUD | 22.9 | |
FR |
![]() |
Vinci SA
PAR:DG
|
68B EUR | 6.7 |
|
IN |
![]() |
Larsen & Toubro Ltd
NSE:LT
|
5T INR | 19.9 |
|
IN |
![]() |
Larsen and Toubro Ltd
F:LTO
|
48.1B EUR | 19.7 |
|
US |
![]() |
Quanta Services Inc
NYSE:PWR
|
56.2B USD | 26.6 |
|
NL |
![]() |
Ferrovial SE
AEX:FER
|
33.9B EUR | 29.6 |
|
ES |
![]() |
Ferrovial SA
MAD:FER
|
34B EUR | 29.6 |
|
CN |
C
|
China State Construction Engineering Corp Ltd
SSE:601668
|
236.3B CNY | 7 |
|
US |
![]() |
EMCOR Group Inc
NYSE:EME
|
27.3B USD | 16.4 |
|
CA |
![]() |
WSP Global Inc
TSX:WSP
|
36.6B CAD | 17.4 |
|
US |
![]() |
Comfort Systems USA Inc
NYSE:FIX
|
24.4B USD | 22.4 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
AU |
![]() |
GenusPlus Group Ltd
ASX:GNP
|
Average EV/EBITDA:
19.8
22.9
|
36%
|
0.6 | |
FR |
![]() |
Vinci SA
PAR:DG
|
6.7
|
6%
|
1.1 |
|
IN |
![]() |
Larsen & Toubro Ltd
NSE:LT
|
19.9
|
19%
|
1 |
|
IN |
![]() |
Larsen and Toubro Ltd
F:LTO
|
19.7
|
19%
|
1 |
|
US |
![]() |
Quanta Services Inc
NYSE:PWR
|
26.6
|
20%
|
1.3 |
|
NL |
![]() |
Ferrovial SE
AEX:FER
|
29.6
|
11%
|
2.7 |
|
ES |
![]() |
Ferrovial SA
MAD:FER
|
29.6
|
11%
|
2.7 |
|
CN |
C
|
China State Construction Engineering Corp Ltd
SSE:601668
|
7
|
8%
|
0.9 |
|
US |
![]() |
EMCOR Group Inc
NYSE:EME
|
16.4
|
8%
|
2.1 |
|
CA |
![]() |
WSP Global Inc
TSX:WSP
|
17.4
|
14%
|
1.2 |
|
US |
![]() |
Comfort Systems USA Inc
NYSE:FIX
|
22.4
|
16%
|
1.4 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.